Trial intelligence / Profile preview

Hydrocortisone and THC effects on fear extinction in healthy adults with or without early-life stress

NL-OMON50765Phase 2Completed

Sponsor
Radboud University Medical Center
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium oxybate, hydrocortisone in post-traumatic stress disorder (PTSD), anxiety disorder, sponsored by Radboud University Medical Center. Started Oct 2019; status: completed.

02

Drugs

sodium oxybatehydrocortisone
03

Conditions

post-traumatic stress disorder (PTSD)anxiety disorder

Beyond the preview

Go deeper on NL-OMON50765.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON50765.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call